Recent Updates
Recently added Catalysts
TVGN Positive Sentiment

Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts

Tuesday, April 29, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Tevogen Bio Holdings Inc. has informed shareholders about the differences between Direct Registration System (DRS) accounts and brokerage accounts. DRS accounts allow shares to be registered directly in the shareholder's name, potentially reducing transaction and maintenance costs. While brokerage accounts may offer quicker selling options and access to various tools, shareholders are encouraged to consider the benefits of DRS accounts.
Price reaction · baseline $46.87 (2025-04-28 close) · hit after-hours · 1 other TVGN headline(s) in the window, move may be shared
day 0 close
+7.7%
day 1
+9.9%
day 3
+7.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Tevogen provides shareholders with clear information about DRS accounts.
  • Direct control over shares in DRS accounts may empower investors.
  • Reduced transaction and account maintenance costs may benefit shareholders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~1 mo
High dilution risk
Lead asset
Cytotoxic T Lymphocytes
Phase 1 · Covid19

Full Press Release Details

WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today informed shareholders about several differences between holding shares in Direct Registration System (“DRS”) accounts and holding them in brokerage accounts.
A DRS account is an alternative to using a brokerage account and Tevogen encourages shareholders to explore the differences. DRS accounts ensure your shares are registered directly in your name and not held through intermediary brokers, allowing shareholder to exercise direct control over their shares. DRS accounts may also have reduced transaction and account maintenance costs for shareholders. Brokerage accounts may provide greater access to tools, and selling shares in this type of account may be quicker when compared to a DRS account. Investors may also incur certain costs in connection with transferring shares in and out of a brokerage account.
For more information about these and other differences, please contact the Company’s transfer agent, Continental Stock Transfer & Trust.
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701

Frequently Asked Questions

What is a Direct Registration System (DRS) account?

A DRS account allows shares to be registered directly in your name, unlike brokerage accounts.

How do DRS accounts benefit shareholders?

DRS accounts provide direct control over shares and may lower transaction and maintenance costs.

Are brokerage accounts faster for selling shares?

Yes, selling shares in brokerage accounts is generally quicker than in DRS accounts.

What are potential costs of brokerage accounts?

Investors may face costs when transferring shares in and out of brokerage accounts.

Who can I contact for more information on DRS?

For more details, reach out to Tevogen's transfer agent, Continental Stock Transfer & Trust.

ShareAdd on Google
Tags: TVGN Viatris Investor Conferences Healthcare Tevogen DRS accounts brokerage accounts shareholder benefits
Last updated: Apr 29, 2025

Biotech snapshot

Cash runway
$1M liquidity · $1M/mo burn
~1 mo
High dilution risk
Lead asset
Cytotoxic T LymphocytesPhase 1
Covid19 →